(Q35129715)

6 August 2017

1 reference

title

Activation-induced cell death in T cells (English)

1 reference

activation-induced cell death of T cells

6 August 2017

main subject

1 reference

Gene Ontology release 2020-05-02

1 reference

Nathalie Droin

2

0 references

Douglas R. Green

object named as

Douglas R Green

series ordinal

1

0 references

author name string

Michael Pinkoski

series ordinal

3

1 reference

6 August 2017

publication date

1 June 2003

1 reference

6 August 2017

published in

Immunological Reviews

1 reference

6 August 2017

volume

193

1 reference

6 August 2017

page(s)

70-81

1 reference

A matter of life and death

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Activation-driven programmed cell death and T cell receptor zeta eta expression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Programmed cell death and extrathymic reduction of Vβ8+CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

A delayed-type hypersensitivity reaction initiated by a single T lymphocyte

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Induction of apoptosis in fibroblasts by c-myc protein

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Apoptotic cell death induced by c-myc is inhibited by bcl-2.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Cooperative interaction between c-myc and bcl-2 proto-oncogenes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Delayed kinetics of T lymphocyte anergy and deletion in lpr mice.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Fas ligand mediates activation-induced cell death in human T lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Metalloproteinase shedding of Fas ligand regulates beta-amyloid neurotoxicity.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Fas ligand (CD95 ligand) controls angiogenesis beneath the retina

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Thymineless death in colon carcinoma cells is mediated via fas signaling

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Fas ligand: a sensor for DNA damage critical in skin cancer etiology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

A common E2F-1 and p73 pathway mediates cell death induced by TCR activation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

The survival of antigen-stimulated T cells requires NFkappaB-mediated inhibition of p73 expression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

A role for FADD in T cell activation and development

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

The suicide in the thymus, a twisted trail

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Sensitivity of S49.1 cells to anti-CD95 (Fas/Apo-1)-induced apoptosis: effects of CD95, Bcl-2 or Bcl-x transduction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytesin vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Induction of apoptosis in mature T cells by tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

The role of Fas ligand in immune privilege

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

TRAIL: a mechanism of tumor surveillance in an immune privileged site

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

The Fas counterattack: cancer as a site of immune privilege

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Visualizing the generation of memory CD4 T cells in the whole body

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

In vivo activation of antigen-specific CD4 T cells.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Tumor necrosis factor alpha up-regulates non-lymphoid Fas-ligand following superantigen-induced peripheral lymphocyte activation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Protein transfer of preformed MHC-peptide complexes sensitizes target cells to T cell cytolysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

The liver as a site of T-cell apoptosis: graveyard, or killing field?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand-deficient mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Inhibition of TNF-induced apoptosis by NF-kappa B.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

The role of c-FLIP in modulation of CD95-induced apoptosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Functional Myc-Max heterodimer is required for activation-induced apoptosis in T cell hybridomas.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Expression of Fas ligand in activated T cells is regulated by c-Myc

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

A 'non-canonical' DNA-binding element mediates the response of the Fas-ligand promoter to c-Myc.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Transcription factors of the NFAT family: regulation and function

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Constitutive Fas ligand gene transcription in Sertoli cells is regulated by Sp1.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Sequential involvement of NFAT and Egr transcription factors in FasL regulation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Missing pieces in the NF-kappaB puzzle

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Fas ligand, death gene.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Regulation of FasL by NF-κB and AP-1 in Fas-dependent Thymineless Death of Human Colon Carcinoma Cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Suppression of Akt signaling induces Fas ligand expression: involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00051.X

7 January 2021

10.1034/J.1600-065X.2003.00051.X

Identifiers

DOI

1 reference

6 August 2017

1 reference